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Abstract
Chronic lung infections are among the most diffused human infections, being often associated with multidrug-resistant bac-
teria. In this framework, the European project “Light4Lungs” aims at synthesizing and testing an inhalable light source to 
control lung infections by antimicrobial photoinactivation (aPDI), addressing endogenous photosensitizers only (porphyrins) 
in the representative case of S. aureus and P. aeruginosa. In the search for the best emission characteristics for the aerosolized 
light source, this work defines and calculates the photo-killing action spectrum for lung aPDI in the exemplary case of cystic 
fibrosis. This was obtained by applying a semi-theoretical modelling with Monte Carlo simulations, according to previously 
published methodology related to stomach infections and applied to the infected trachea, bronchi, bronchioles and alveoli. 
In each of these regions, the two low and high oxygen concentration cases were considered to account for the variability of 
in vivo conditions, together with the presence of endogenous porphyrins and other relevant absorbers/diffusers inside the 
illuminated biofilm/mucous layer. Furthermore, an a priori method to obtain the “best illumination wavelengths” was defined, 
starting from maximizing porphyrin and light absorption at any depth. The obtained action spectrum is peaked at 394 nm 
and mostly follows porphyrin extinction coefficient behavior. This is confirmed by the results from the best illumination 
wavelengths, which reinforces the robustness of our approach. These results can offer important indications for the synthesis 
of the aerosolized light source and definition of its most effective emission spectrum, suggesting a flexible platform to be 
considered in further applications.
Keywords Antimicrobial photoinactivation · Chronic lung infections · Photo-killing action spectrum · Monte Carlo 
simulation · Pseudomonas aeruginosa · Staphylococcus aureus
1 Introduction
In the context of antibiotic resistance (ABR), lung chronic 
infections are among the most affected worldwide [1–3]. For 
example, Pseudomonas aeruginosa infection is the leading 
cause of morbidity and mortality in cystic fibrosis patients, 
while methicillin-resistant Staphylococcus Aureus is among 
the hospital-acquired chronic and acute lung infection with 
most clinical interest [4]. The only available treatment for 
these infections is the use antibiotics, inhalable compounds 
being favoured over systemic ones mainly due to their higher 
deposition ratio at the site of the infection [5]. Current anti-
biotics are insufficiently effective because of their wide use 
which often induces ABR and for the presence of bacterial 
biofilm which represents their defence strategy against anti-
biotics [6].
In this context, both antimicrobial PDT (aPDT) and aPDI 
can play an important role in overcoming ABR, with or 
without the use of external photosensitizers and/or the con-
temporary use of antimicrobial compounds [7–9]. In human 
applications of aPDT, most results are either related to 
in vitro or ex vivo proof-of-principle experiments or concern 
the in vivo treatment of external organs, such as the case 
of skin and mucosal infections [10] due also to the relative 
facility in designing and using illumination sources. PDT 
clinical applications in the case of internal organ diseases is 
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increasingly growing, even if the vast majority of applica-
tions are in the antitumor field [11].
In the case of the lungs, research has been concentrat-
ing in antitumor PDT since long time [12], results about 
aPDT applications being relatively more recent [13–16]. In 
the case of PDT, we cannot exclude the presence of exter-
nal photosensitizers (PS). Differently, in aPDI, the therapy 
is based only on endogenous PS in the form of bacterial 
porphyrins; of course, the therapeutic outcome would be 
much increased by the presence of external PS, this having a 
downside associated in particular to the requirement of spec-
ificity and the introduction of a pharmacologic treatment 
instead of a light-treatment only. Even if most bacteria are 
known to contain porphyrins [17], many good photo-killing 
results have been obtained on few species and in particular 
S. aureus and P. aeruginosa, whose intrinsic photosensitiv-
ity is well known to the scientific community [18], even 
if the biofilm they produce as the pathogenesis progresses 
introduces a difficulty for the success of the phototherapeutic 
approach [19].
In any case, both aPDT and aPDI suffer intrinsically 
from the difficulty in illuminating all the pathology-affected 
regions (e.g. bronchi, alveoli), which depend on the pathol-
ogy and its grade and development in time. Till now, solu-
tions for therapeutic light delivery in the lungs have consid-
ered the use of modified bronchoscopes and optical fibers 
[13, 16] and external illumination [20], always in combina-
tion with exogenous photosensitizers [21]. Very few works 
report phantom or ex vivo studies to design illumination 
schemes for therapeutic purpose [14], the majority of them 
analysing diagnostic illumination schemes.
In this context, the Light4Lungs European project aims to 
define, synthesize and evaluate the efficacy of an inhalable 
light source in the form of a light-emitting phosphorescent 
aerosol, to contain chronic lung infections associated to S. 
aureus and/or P. aeruginosa, without external PS to increase 
the minimally invasive character of the proposed therapeutic 
scheme. The emission characteristics of the aerosol particles 
have to be carefully planned, to exploit every emitted photon 
in the best way. In addition to the emission lifetime, in the 
5–30 s timespan, one of the most important requirements 
is the optimization of the photo-killing efficacy against the 
chosen representative species (S. aureus, P. aeruginosa), 
taking into account the presence of biofilm on the lumen 
wall of the lung airways. Focusing our attention to the repre-
sentative case of cystic fibrosis patients, all lung regions can 
in principle be affected by the associated infections (trachea, 
bronchi, bronchioles and alveoli, see for example [22]) but 
at the same time all regions can be reached by light via the 
aerosol, provided the chemo-physical characteristics of the 
aerosol particles are properly defined and obtained. This a 
priori possibility to target with light all lung regions is in 
itself a great advantage, which could be exploited beyond 
the case of cystic fibrosis. This aspect further justifies the 
choice to include all lung regions in our model.
To take advantage of all the emitted photons, light thera-
peutic efficacy has to be maximized, bearing in mind the 
geometry and physics of light interaction with the biofilm 
and the mucous (BM layer) and, possibly, the underlying tis-
sues. Therefore, a careful analysis of light–bacteria interac-
tion in the infected lung environment can provide important 
information about the required emission spectrum for the 
aerosol particles.
To this aim, this communication proposes a method to 
find the action spectrum for bacteria photo-killing in the 
above-described conditions, relying on endogenous PS only. 
The aerosol was modelled by a homogeneous and diffuse 
light source inside the airways, illuminating the BM layer 
deposited onto the wall of the airway lumen and inside the 
alveoli, regardless of the specific and preferential locali-
zation of the aerosol in a real specific case. This, in fact, 
depends on many factors (chemo-physics of the aerosol 
particles, aerosolization process, aerosol intake protocol, 
airways conditions) and is beyond the scope of this article; 
it has to be considered that in any situation, the aerosol will 
be always localized in the entire lung, still being it possible 
to predict (or measure) its repartition among the various 
regions.
On the other hand, light–BM layer interaction was mod-
elled applying the same method used for previous publica-
tion on the photo-killing action spectrum in the stomach 
[23]. Monte Carlo simulations were performed following 
geometrical modelling and analysis of the relevant optical 
parameters taken from the literature. Final results were com-
pared with a second method, defining the best illumination 
spectrum and starting from optimization of bacteria por-
phyrin absorption within the BM layer. The obtained curves 
were then compared with porphyrin absorption coefficient 
and analysed to derive indications for the spectrum of the 
aerosol particle emitters.
2  Experimental
2.1  Pathological conditions 
and anatomo‑functional model
The pathological conditions considered in this study cor-
respond to those correlated with cystic fibrosis, which is 
associated with the presence of either P. aeruginosa or 
S. aureus species (or both) in the form of biofilm. In the 
perspective of studying light–tissue interaction by use of 
the luminous aerosol, this pathologic condition was mod-
elled, in the following regions of the bronchial tree: trachea, 
bronchi, bronchioles and alveoli, which were considered 
representative of the aerosol-based therapeutic approach; 
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the related anatomo-pathological data were obtained from 
the literature [24–26]. Following the illumination scheme 
depicted in Fig. 1, the first light target was represented as a 
homogeneous layer of mixed biofilm and mucous compo-
nents (the BM layer) containing both species of P. aerugi-
nosa and S. aureus. In this model, the “mixing” described 
above refers to the definition of a layer whose mass den-
sity, bacteria numerical density, light absorber density and 
optical properties are constant in every point and defined 
as described in the next sections. Being interested in the 
interaction of photons within the BM layer only, this model 
neglects the presence of the underlying tissue (epithelium, 
cartilage, connective tissue). From an optical point of view, 
this corresponds to neglecting the contribution of reflected 
and back-scattered photons at the interface between the BM 
layer and the epithelium.
To account for the variability of in  vivo conditions, 
in each of the aforementioned lung regions two different 
cases were considered i.e. low and high  [O2] (oxygen con-
centration) conditions for the BM layer. In general, these 
correspond to different BM layer thickness and porphyrin 
concentration values and were simulated by varying these 
parameters according to the literature data [27–30] while 
mucous composition was not varied. In particular, porphyrin 
concentration is reported to depend on  [O2] due to metabolic 
adaptation reasons [31]. In our modelling scheme, there-
fore, the two low/high  [O2] cases have been associated to 
two different and representative porphyrin concentrations 
as reported in Table 1.
BM layer mean thickness in low  [O2] conditions was 
derived from literature data about P. aeruginosa biofilm 
thickness in vitro and biofilm + mucous thickness measured 
in cystic fibrosis patients [8, 25]. In particular, BM layer 
thickness in high  [O2] conditions was estimated by adding 
bacterial biofilm thickness in vitro [8, 32] to the mucous 
thickness in a normal (non-pathologic) patient [25]. In the 
following table, we resume the modelled conditions for 
Fig. 1  Schematic model of the aerosol-based illumination of the lung 
airways. Therapeutic photons are emitted from the lumen volume and 
surface, encountering the BM layer first, then the underlying tissue
Table 1  BM layer characteristics showed in a and b
(a) BM layer characteristics for all regions and conditions
Absorption Scattering Refractive index Absorber and bacteria concentration with depth
Water [46], Mucin [47], PPIX (https:// omlc. org), 
Coproporphyrin [33], Uroporphyrin [34], Pyo-
cyanin [35], Carotenoids [36]
10% Intralipid® [39] n = nwater Constant
(b) BM layer peculiar characteristics according to the specific region and condition
Region Condition
Characteristics High  [O2] Low  [O2]
Trachea/Bronchi Mean thickness 52 µm 500 µm
Bacteria density 108 CFU/ml 108 CFU/ml
Porphyrin concentration 1.06 ·  10–8 M 7.56 ·  10–8 M
Oxygen gradient 230–160 µM 230–10 µM
Bronchioles Mean thickness 43 µm 300 µm
Bacteria density 108 CFU/ml 108 CFU/ml
Porphyrin concentration 1.06 ·  10–8 M 7.56 ·  10–8 M
Oxygen gradient 230–170 µM 230–33 µM
Alveoli Mean thickness 40 µm 100 µm
Bacteria density 108 CFU/ml 108 CFU/ml
Porphyrin concentration 1.06 ·  10–8 M 7.56 ·  10–8 M
Oxygen gradient 230–170 µM 230–120 µM
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each region and for both the high  [O2] and low  [O2] cases. 
The list of the representative species characterizing the BM 
layer absorption properties is the following: water, mucin 
(from mucous), protoporphyrin IX (PPIX) (https:// omlc. 
org), coproporphyrin [33] and uroporphyrin [34], pyocyanin 
(from P. aeruginosa) [35], carotenoids (from S. aureus) [36]. 
In particular, in all conditions and regions mucin concentra-
tion has been defined to be 5% [37], while the porphyrin 
types and their relative concentration have been evaluated 
as a function of both the bacteria species and the presence 
of low / high  [O2] as described before. The in vivo CFU 
concentration for both P. aeruginosa and S. aureus was taken 
from literature data [24, 38] and considered the same for 
both species.
On the other side, the BM layer scattering properties were 
modelled by considering the measured scattering coefficient 
of the Intralipid® colloid [39] (see also next section). In 
fact, Intralipid® is a lipid emulsion used e.g. in parenteral 
nutrition, which is widely considered as a testing scattering 
medium for tissue phantom generation.
2.2  Optical properties
Before performing the Monte Carlo simulations, we first 
calculated the BM layer optical properties for each region 
and condition in terms of refractive index (n) and absorp-
tion, scattering and anisotropy coefficients (μa(λ), μs(λ), g(λ), 
respectively).
In particular, μa was obtained following the Lambert–Beer 
law for an absorbing medium containing multiple species:
where μai is the absorption coefficient of the i-th species, 
εi and ci are the extinction coefficient and molar concentra-
tion of the i-th species, respectively (see Table 1 for the list 
of the absorbing species).
As anticipated, the values for μs(λ) and g(λ) were taken 
from literature [39]. For all cases, in the absence of specific 
information regarding the variability of the scattering coef-
ficient of the BM layer with the lung region and/or the pres-
ence of aerobic/anaerobic conditions. Finally, the BM layer 
refractive index was approximated to that of pure water [40].
2.3  Action spectrum
Following the methodology present in other studies [23], the 
action spectrum for bacterial photo-killing for each chosen 








(2)K() = T() () (),
where T(λ) is the transmittance of a  Deff-thick layer, rep-
resenting an effective thickness for the BM layer, as detailed 
in the following; ε(λ) is the porphyrin molar extinction 
coefficient, defined as an averaged mean over their relative 
concentration; φ(λ) is the porphyrin quantum yield for ROS 
production [41]. To obtain T(λ), for each chosen region 
(“bigger” bronchi, “smaller” bronchi, alveoli) the problem 
is restricted to a one-dimensional model, with a two-step 
approach:
Step 1: reduction of the initial 3D problem into a one-
dimensional model and definition of an effective thickness 
 Deff for the BM layer in the specific region (trachea, bigger 
bronchi, smaller bronchi, alveoli) and condition (high  [O2]/
low  [O2]). This is depicted in Fig. 2, where the first line 
refers to the case of trachea, bigger and smaller bronchi, 
which have the same cylindrical geometry; the second line 
refers to the alveoli case and the third bottom line refers to 
the one-dimensional reduction of the problem and definition 
of the problem geometry.
Following the methodology present in previous studies 
[23],  Deff was obtained in three steps. First, we analysed the 
problem geometry (cylindrical for trachea, bronchi and bron-
chioles, spherical for alveoli) and obtained dmax as a function 
of the incidence angle (α in Fig. 2) in a planar geometry 
that simplifies the more complex 3D geometrical problem 
(see Fig. 2). This hypothesis was justified in retrospect, as 
explained below.
Then, deff (α) was obtained by means of a weighted mean 
of the depth inside the BM layer (x in Eq. 3) in the range 
0–dmax():
where 1/μ is the average light penetration depth in the BM 
layer. The weighting factor e−x represents the Lambert–Beer 
exponential decrease of light power and, therefore, the con-
sequent decrease in bacteria photokilling efficacy.
In Eq. 3, μ was derived according to Eq. (1), while dmax 
was calculated by a geometrical modelling of the specific 
region conditions (see Fig. 2). Finally,  Deff was obtained by 
averaging deff (α) over the incidence angle α:
Step 2: perform a Monte Carlo simulation on a  Deff-thick 
BM layer to obtain T(λ), as detailed below. In general, a 
purely analytical approach to the calculation of dmax (α) 
and deff (α) is very complex if the BM layer 3D structure 
is explicitly considered, as it would imply the dependence 
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would be associated to the “exact” calculation of dmax and 
deff, then of  Deff. The maximum difference respect to our 
calculated values for  Deff was estimated to be of about 10% 
for all regions (data not shown), with very acceptable conse-
quences on the final estimated value for the action spectrum 
(see section on error analysis).
2.4  Monte Carlo simulation
The Monte Carlo simulation was used to obtain T(λ) (Eq. 2) 
and also for successive analysis to obtain the “best illumi-
nation spectrum”, as described below. The simulation was 
performed using the MCML free software [42] and pur-
posely made data-analysis routines (MatLab v.R2020A and 
Microsoft Excel 2020). The software defines a vertically 
impinging photon flux; in our case we considered the follow-
ing photon-related parameters for the simulation: wavelength 
range 380–700 nm, being Δλ = 1 nm between two successive 
wavelengths;  106 photons per chosen wavelength. Photons 
were considered to be incident from air into a homogeneous 
medium representing the BM layer.
2.5  Best illumination wavelengths
To have a confirmation of the robustness of the method used 
to obtain the action spectrum, we developed a methodology 
to calculate the “best illumination wavelength”, defined as 
the one maximizing bacterial porphyrin excitation in our 
Fig. 2  Modelling of representative lung regions. First line: represen-
tation of the cylindric geometry for trachea, bronchi and bronchioles 
(a, b); definition of the dmax parameter as a function of the illumina-
tion geometry in every point of the BM layer surface (c). Second line: 
representation of a spherical geometry for alveoli (d, e); definition of 
dmax as a function of the illumination geometry (f). Third line: defini-
tion of  dmax as a mean over the illuminated surface by representation 
of the equivalent unidimensional case (g, h); definition of  Deff (i)
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modelled conditions. This definition is intrinsically arbitrary, 
being possibly substituted by other definitions that explicitly 
consider the consequent formation of ROS and/or bacterial 
cell photo-killing efficacy. Nevertheless, in this context we 
preferred to stop at the stage of PS excitation, leaving con-
siderations on the biological consequences to future work.
In the following, we start from considering the desired 
photon wavelength and number at each depth  zi inside the 
BM layer, and consequently derive the desired character-
istics of the impinging light in terms of wavelength(s) and 
photon number. Referring to Fig. 3, let us divide our prob-
lem into two steps, where we define the wavelength (λbest) 
and number of photons (nbest) maximizing porphyrin exci-
tation in a volume ΔV inside the BM layer containing np 
porphyrin molecules, being nbest intended as the minimum 
photon number associated to that purpose:
Case 1) np porphyrins at z = 0:
λbest = peak wavelength of the function ε(λ) for all photons 
and nbest = np / ε(λbest).
This choice maximizes the excitation probability, consid-
ering that no photon absorption is present before interaction 
with the porphyrins.
Case 2)  np porphyrins in the layer between zi and zi + Δz, 
with 0 < zi ≤ H:
λbest = peak wavelength of the function ε’(λ) = ε(λ) T(λbest, 
z) for all photons and nbest = np/(ε(λbest) T(λbest, z)) where 
T (λbest, z) comes from the Monte Carlo Simulation. It is 
worth noticing that this choice accounts for the presence of 
both absorption and scattering of all the BM layer above the 
porphyrin depth, there included porphyrin absorption itself. 
Respect to case 1, here we have to further raise the photon 
number arriving at depth = z by taking into account photon 
extinction due to a z-deep BM layer.
By repeating this method for any depth up to z = H, we 
can build a discrete impinging light spectrum Si = S(λi) 
where i = 1, …, N numbers the BM layers of equal thickness 
Δz (i = 1 being the top one), λi and ni = n(λi) being equal to 
λbest and nbest for the i-th layer, respectively.
2.6  Error analysis
Errors in obtaining the action spectrum and the best exci-
tation wavelengths were associated to the reproducibility 
of the obtained results.
Starting from the very many variables involved, we ana-
lysed the variation of the action spectrum as a function of 
the chemo-physical and optical parameters as well as the 
geometrical ones:
 (i) bacterial porphyrin concentration (from: modelling 
of the pathological conditions);
 (ii) geometry parameters (from: modelling of the patho-
logical lung anatomy, e. g. BM layer thickness);
 (iii) optical characteristics of the absorbers e.g. µa e µs;
 (iv) Deff, associated to the methodology to reduce the 
problem to a mono-dimensional one.
All these parameters have been used, directly or indi-
rectly, to calculate the action spectrum K (λ) (Eq. 2). Due 
to its key role in representing the problem geometry and 
for performing the Monte Carlo simulation,  Deff was con-
sidered as the main parameter whose variation summa-
rized the presence of multiple errors in the overall method. 
The dependence of the action spectrum curve on  Deff was 
tested by imposing an arbitrary but reasonable variation 
of ± 10% on the  Deff value, representative of the overall 
error on its determination. Here, two different analysis 
were performed:
 (i) variation in the action spectrum shape, i.e. in K (λ) 
curves for  Deff best and  Deff best ±10%, all normalized 
at their respective maximum;
 (ii) variation in the action spectrum curve values respect 
to the best case, i.e. analysis of the 3 curves K best = 
K (λ,  Deff best), K+ = (λ,  Deff best +10%), K– = K (λ, 
 Deff best -10%).
Fig. 3  Scheme representing the 
model used to define the best 
excitation light spectrum for 
endogenous bacteria porphy-
rins in the BM layer.  np is the 
number of porphyrins in each 
Δz layer at depth zi
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In particular, case (ii) is important when comparing 
action spectrum values at 2 different wavelengths. Referring 
to the generic representative scheme shown in Fig. 4, the rel-
ative photokilling efficacy at λ1 respect to λ2 is represented 
by the ratio K best (λ1)/K best (λ2), which in turn depends on 
the variability (“error”) depicted by the vertical segments in 
correspondence of λ1 and λ2, respectively, and suggesting an 
error propagation procedure. In addition, the influence of the 
concentration parameters on the BM layer transmittance was 
tested, by imposing a separate ± 10% variation in µa and µs 
respectively and testing its influence on K ( λ).
Due to the primary role of endogenous porphyrins in 
aPDI, their concentration was varied of ± 1 order of mag-
nitude respect to the chosen representative value (Table 1), 
maintaining all the other parameters constant. This choice 
is justified by the variability in the bacterial CFU counts/ml 
found in literature studies. The action spectrum curves were 
correspondingly obtained.
Finally, the light irradiance reflected back into the BM 
layer by the underlying tissue  (ER) was first estimated in 
terms of expected mean reflectance R. This was done by 
applying the Fresnel equations at the interface between 
the BM layer and the successive tissue, limiting our analy-
sis to the normal incidence case. To apply the simplified 
Fresnel equation, we considered n = 1.33 for the BM layer 
and n = 1.37 [43] for the underlying tissue. Starting from R, 
the ratio between  ER and the irradiance at the lumen side of 
the BM layer (“impinging irradiance”) was also estimated.
3  Result and discussion
3.1  Deff values
The results for the  Deff values are resumed in Table 2. These 
values reflect in part the dimensions of the different lung 
regions; better, we should consider that the mean operation 
over the geometrical variables defining  dmax gives similar 
results for different lung regions, namely trachea, bronchi 
and bronchioles. This is due to the longitudinal and trans-
versal dimensions (L and S respectively, Fig. 2) being such 
that L >  > H, considering that mean values for L are in the 
1.3 cm range for bronchioles and 5–12 cm for bronchi and 
trachea [44].
Following Eq. 3, the maximum theoretical value for  Deff 
can be obtained by considering dmax =  + ∞ for all α, which 
gives  Deff = 1/μ ≈ 290 μm for both cases, being μ = 34.6  cm−1 
and 34.2  cm−1 for P. aeruginosa and S. aureus, respectively.
In general, in fact, the exponentially decreasing behaviour 
of the weighting factor (see Eq. 2 and 20) defining  Deff, miti-
gates its dependence on the geometrical parameters, which 
in turn results in a small variation of the normalized action 
spectrum curve. In other words, sensitive relative variations 
in dmax (due to modelling errors or anatomical variability) 
do not result in sensitive variations in the final action spec-
trum shape.
It is worth mentioning that, unlike [23] here we have a 
diffused light source (a luminous aerosol), meaning that light 
emitters can be located in any point inside the lumen includ-
ing the lumen surface. The averaging operation that defines 
 Deff is compatible with this condition but does not take into 
account any possible influence (if any) of a non-uniform 
aerosol distribution (emitter density) along the specific air-
way region. In other terms, our approach remains valid in 
the case of a non-uniform aerosol distribution provided it 
happens at the whole lung scale level and not on a local one, 
which corresponds to a realistic expectation [21].
3.2  Action spectrum
The results for the action spectrum are shown in Fig. 5a. 
Starting from 16 possible cases (2 bacteria types, 2 condi-
tions, 4 regions) the normalized action spectrum curves were 
grouped into 4 categories (1 to 4, Table 3). The differences 
between these 4 curve types can be found in:
 (i)  a dissimilar behaviour in the 410-430 nm region;
 (ii)  a different value of the secondary peaks.
Fig. 4  Scheme depicting the influence of action spectrum variability 
on the determination of the relative efficacy of two generic wave-
lengths λ1 and λ2
Table 2  Deff values, shown for the P. aeruginosa case
Results for the case of S. aureus are substantially coincident within 
few percent (e.g. 186 μm for the bronchioles case—low  [O2] condi-
tions)
Deff values (μm)
Trachea Bronchi Bronchioles Alveoli
Low  [O2] 232 212 184 53
High  [O2] 61 57 53 57
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Both of these features appear to be ancillary and can be 
attributed to differences in e.g. porphyrin and pigment types/
concentrations between P. aeruginosa and S. aureus. Possi-
bly, the variation in secondary to primary peak ratio in types 
1–3 respect to 2–4 can be considered as the most important 
modulation over the various cases considered, which can be 
useful in evaluating the possible use of additional red light 
in excitation.
In all cases, the action spectrum is peaked at around 
395 nm for both P. aeruginosa and S. aureus cases, being it 
a weighted mean over uroporphyrin (~ 400 nm), copropor-
phyrin (~ 395 nm) and protoporphyrin (~ 410 nm) peaks. 
The most important feature of the action spectrum curves 
is their close similarity to the porphyrin molar extinction 
coefficient, as illustrated in Fig. 5b. If on one side this could 
seem surprising, we have to consider that the absence of 
strong antagonistic absorbers with peculiar absorption peaks 
respect to porphyrins (visible range) is a key factor that ulti-
mately contributes to the similarity described above and 
overall also to the robustness of the proposed method.
In this analysis, we should enquire the role of 
mucin + bacteria pigments pyocyanin and carotenoids, dis-
carding water (whose absorption is negligible in the visible 
over ~ 100–300 μm range) and considering that in a first 
approximation the scattering acts as an absorption enhancer. 
Of course, as the simulation takes into account the absorp-
tion coefficient (μa in Eq. 1), we have to carefully consider 
also the relative absorber concentration. If on one side, 
mucin contribution to the μa is substantial, nevertheless its 
almost constant (slightly decreasing) behaviour in the vis-
ible range does not shift the action spectrum peak from the 
porphyrin main peak region, still and possibly contributing 
to decreasing the importance of the secondary peaks in the 
yellow–red. On the other side, the pigments’ extinction coef-
ficients are peaked at ~ 300 nm for pyocyanin and ~ 460 nm 
for carotenoids but their concentration is not high enough to 
result in a significant contribution to the final μa.
3.3  Error analysis
According to the proposed methods, the K best,  K+ and  K- 
curves have been obtained and compared for all cases. Their 
normalized values do not show any appreciable difference 
over the whole wavelength range (data not shown), which is 
indicative of the robustness of the method.
The comparison between the curves, normalized respect 
to K best maximum, is shown in Fig. 6 in the exemplary 
cases corresponding to categories 1 and 2. Deviations 
respect to the  Kbest values are ± 8–18% for category 1 and 
± 2–4% for category 2, considering the whole wavelength 
range 380–700 nm. Besides, a ± 10% variation of the opti-
cal parameters μa and μs resulted in a transmittance varia-
tion for the BM layer of about ± 5% and ± 4%, respectively, 
which in turn was associated to a negligible variation in the 
action spectrum values. Finally, the estimated back-reflected 
light fraction by the tissues beneath the BM layer is of about 
Fig. 5  Normalized action spectrum for bacterial photo-killing in the lungs. a Associated to the four categories (see Table 3); b Comparison to 
porphyrin absorption spectrum (action spectrum: exemplary case related to category 2—P. aeruginosa high  [O2] and alveoli low  [O2])
Table 3  Subdivision of bacterial 
models into 4 main sub-
categories, distinguishing them 
into regions (trachea, bronchi, 
bronchiole and alveolus) and 
conditions (high  [O2]/low  [O2])
Error analysis was performed in only two representative cases of P. aeruginosa: anaerobic trachea and aer-
obic alveolus
P. aeruginosa S. aureus
Trachea Bronchi Bronchioles Alveoli Trachea Bronchi Bronchioles Alveoli
Low  [O2] 1 1 1 2 3 3 3 4
High  [O2] 2 2 2 2 4 4 4 4
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2⋅10–4. This gives in any case a negligible value (< < 1%) for 
the irradiance fraction re-entering the BM layer, respect to 
the irradiance incident at the lumen level.
Finally, the action spectrum curves obtained by varying 
the bacterial CFU/ml between  107 and  109 showed no sig-
nificant variations (data not shown).
3.4  Best illumination wavelengths
In all cases, the result for best illumination wavelengths 
(as defined in the “Materials and methods”) give the only 
λ = 394 nm, in accordance with the action spectrum main 
peak. The presence of a single wavelength (corresponding to 
an ideally very narrow illumination spectrum) is not surpris-
ing. In fact, the method selects only the peak wavelength of 
ε’(λ) (see Fig. 3), at any depth inside the BM layer. Analysis 
of the ε’(z, λ) behaviour shows that the importance of the 
main peak decreases with increasing depth, while secondary 
peaks increase but not to the point of overcoming the main 
one, at least for the thickness values considered in our model 
(data not shown).
4  Conclusions
This work is related to the development of an innovative 
and inhalable light source in the form of a luminous aero-
sol, to control lung infections associated to the presence of 
S. aureus and/or P. aeruginosa. As an exemplary case, we 
considered the anatomic-pathological conditions associated 
with cystic fibrosis, one of the most important targets of the 
proposed therapeutic approach based on aPDI in the lungs. 
Following previous work related to aPDI in the stomach, we 
started by applying the same semi-theoretical methodology 
to derive the in vivo action spectrum for bacterial photokill-
ing in the lungs. The robustness of the method was tested 
by applying a second methodology to obtain an independent 
confirmation on the characteristics of the best illumination 
wavelengths optimizing endogenous PS absorption.
One of the main risks associated with minimally inva-
sive techniques for light delivery in PDT/aPDT/aPDI is their 
intrinsic lack of photons or, better, lack of “intensity” defin-
able as the irradiance at the level of the relevant tissue/ana-
tomical region. That is why, considering a PS-free approach 
for exogenous compounds, we have interest in maximizing 
the production and efficacy of every single excitation pho-
ton. In this perspective, indications coming from the in vivo 
action spectrum are fundamental to optimize the therapeutic 
efficacy and to guide the synthesis of the best material in the 
form of light emitters included in the aerosolization process.
Unlike previous results for the stomach, in this case the 
final indications for the best excitation spectrum are in the 
end pretty straightforward: the action spectrum is substan-
tially coincident with the endogenous porphyrin extinction 
coefficient. This difference is due to a different localization 
of the infection: planktonic bacteria and bacteria in biofilm 
are not hidden in between tissue plicae and rugae as in stom-
ach infection by H. pylori, but grow onto the lumen surface 
of the lung airways, so that tissue optical properties have a 
negligible role respect to those of the BM layer. This, in turn, 
affects the simulation results at the basis of the proposed 
approach.
In fact, starting from geometrical modelling of the 
infected regions (trachea, bronchi, bronchioles and alveoli), 
we reduced the problem to one dimension only, performing 
Monte Carlo simulations on a homogeneous optical means 
representing the BM layer, having an effective thickness rep-
resentative of the physics and geometry of light–BM layer 
interaction. By careful analysis of the relevant literature, 
scattering and absorption were accounted for including in 
particular the presence of mucin (from mucous), endogenous 
bacteria pigments and porphyrins: the main contribution to 
the final absorption coefficient was given by porphyrins only. 
This is due both to the absence of visible absorption peaks, 
still in the presence of a relative high concentration (the case 
Fig. 6  Effect of  Deff variability on the action spectrum. a Cases relative to category 1 (see Table 3); b Cases relative to category 2
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of mucin) and to absorption peaks being accompanied by a 
relatively moderate or low concentration (pigments).
These results were confirmed by the analysis of the best 
illumination wavelengths. In this case, a different method-
ology was used, based on a reversed attitude respect to the 
action spectrum one but answering to the same question. 
This is intrinsically not different from the classic approach 
to PDT, optimally illustrated by Jacques [45]. Starting from 
a homogeneous distribution of porphyrins in the BM layer 
volume, we aimed at having virtually all of them excited 
with maximum probability, taking into account both their 
extinction coefficient and the photon absorption by the BM 
layer itself. By considering all porphyrins at all depths, this 
operation builds up the “best excitation spectrum” for the 
light impinging at the BM layer surface. This method is 
fed by the knowledge of the BM layer transmittance at any 
depth, which was provided by the Monte Carlo simulation. 
Of course, this could be implemented to take into account 
further steps, e.g. oxygen concentration and ROS production 
or even link this with the desired killing effect by introduc-
ing more biology into the problem.
In conclusion, this study proposes a semi-theoretical 
method to obtain the action spectrum for aPDI in the lungs, 
emphasizing the importance of the modelling aspects and 
of a quantitative approach. We believe that the force of this 
methodology is mainly in its flexibility, as it can be appli-
cable to any organ/tissue/region where PDT, aPDT or aPDI 
can be considered as a therapeutic option. Perhaps even 
more interesting, the flexibility is also on the possibility to 
afford the same problem from different perspectives: (i) to 
obtain the efficacy of a given source respect to another; (ii) 
to design the source characteristics fitting them to optimize 
the therapeutic efficacy of a specific case (e.g. optical fibre 
illumination); (iii) to find the limiting factor upon which to 
act primarily to exploit all the potential of a given technique.
Of course, in vitro and in vivo experiments are the natural 
and necessary continuation of this kind of studies.
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